TGFB1 and melanoma: Our study confirmed significantly higher serum levels of both TGFβ1 and TGFβ2 within the melanoma patient cohort, while analysis of lupus patient sera from a previous study identified high levels of TGFβ1 but little TGFβ2 compared with healthy donor sera.